About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Florida | 509 Studies

Clinical Trials Ovarian CancerFlorida

Ovarian Cancer Clinical Trials in Florida

Find 509 clinical trials for ovarian cancer near Florida. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 509 trials

RecruitingTrial of Exercise and Lifestyle for Women With Ovarian and Endometrial CancerAn anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy…NCT05761561·New Haven, Connecticut and 1 other RecruitingInfusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian CancerThe purpose of this first in human study is to evaluate the safety of treatment with autologous T cells genetically modified to express a CER (chimeric endocrine receptor)…NCT05316129·Tampa, Florida TerminatedFOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian CancerThis is a multicenter, multinational, randomized, double-blind, 2-arm, parallel-group, Phase 2/3 study to evaluate the efficacy and safety of PCC plus bevacizumab and CA4P versus…NCT02641639·Birmingham, Alabama and 39 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTo evaluate the efficacy of voloxicimab when administered at 15 mg/kg qwk in subjects with platinum-resistant, advanced epithelial ovarian cancer or primary peritoneal cancer.NCT00516841·Los Angeles, California and 22 others

CompletedPhase I Study of OSI-930 and Erlotinib in Cancer TumorsThis is a Phase I, dose escalation, safety study of OSI-930 and Erlotinib in cancer tumors.NCT00603356·Tampa, Florida and 1 other

Active not recruitingStudy of INCB123667 in Subjects With Advanced Solid TumorsThis is an open-label, dose-escalation and dose-expansion study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of INCB123667 when…NCT05238922·Duarte, California and 40 others

Active not recruitingA Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsThis is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in…NCT07038369·Los Angeles, California and 7 others

CompletedA Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian CancerMORAb-003-011 is a global, multicenter, double-blind, randomized placebo-controlled study to assess the safety and efficacy of farletuzumab in combination with standard…NCT02289950·Phoenix, Arizona and 67 others

RecruitingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsThis study is to evaluate the safety, tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with KRAS G12C-mutated…NCT06128551·Duarte, California and 55 others

RecruitingA Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan…NCT06824467·Birmingham, Alabama and 195 others

CompletedStudy to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian CancerThis is a multicenter, open-label, two-arm, 2-stage, Phase 2 study of NKTR-102 in patients with metastatic or locally advanced platinum-resistant ovarian cancer.NCT00806156·Highland, California and 19 others

Active not recruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsThis phase II trial studies the possible benefits of treatment with different combinations of the drugs durvalumab, olaparib and cediranib vs. the usual treatment in patients with…NCT04739800·Anchorage, Alaska and 390 others

TerminatedA Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)The goal of the study is to learn whether Niraparib or Platinum-Taxane Doublet chemotherapy is better in treating participants with Homologous Recombination Deficient (HRd) Stage…NCT06964165·San Francisco, California and 20 others

Active not recruitingPARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian CancerOf the approximately 21,000 cases of ovarian cancer diagnosed annually in the U.S, ten percent are attributed to hereditary syndromes, most commonly the result of mutations in the…NCT02571725·Tampa, Florida and 4 others

RecruitingA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional…NCT05824975·Scottsdale, Arizona and 10 others

CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerThis phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer.NCT03180294·Anaheim, California and 361 others

CompletedEP0057 in Combination With Olaparib in Advanced Ovarian CancerEP0057-201 is a Phase 2A/B adaptive design study.NCT04669002·Irvine, California and 20 others

CompletedA Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaDasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00671788·Hartford, Connecticut and 19 others

Active not recruitingA Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyThis study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer.NCT02655016·Tempe, Arizona and 115 others

SuspendedA Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid TumorThis is an open-label, Phase 1b/2 study to determine the recommended dose of lucitanib in combination with nivolumab in patients with an advanced solid tumor (Phase 1b); followed…NCT04042116·Los Angeles, California and 26 others

Page 1 of 26Next

Other Conditions in Florida

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia